期刊文献+

N-(3-苯丙基)哌嗪类σ_1受体配体的3D-QSAR研究

3D-QSAR STUDY OF N-(3-PHENYLPROPYL) PIPERAZINE TYPE OF σ1 RECEPTOR LIGANDS
下载PDF
导出
摘要 采用比较分子力场(CoMFA)分析法和比较分子相似性指数(CoMSIA)分析法,对34个N-(3-苯丙基)哌嗪类σ1受体配体进行三维定量构效关系(3D-QSAR)研究,建立了具有较强预测能力的3D-QSAR模型.并利用Gaussian 03程序,采用B3LYP/6-31G(d)方法,探索了化合物分子的前线轨道与分子结构的关系.新设计的化合物的体外受体结合分析结果与该模型预测的数据一致,此结果为进一步研究σ1受体-配体的相互作用模型以及设计高亲和力的哌嗪类σ1受体配体提供了参考. 3D-QSAR of 34 N-(3-phenylpropyl) piperazine type of σ1 receptor ligands was performed with comparative molecular fields analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA). 3D-QSAR models with different conformations were established. The frontier orbits of the above ligands were investigated with B3LYP/6-31G(d) using Gaussian 03 software. The in vitro Ki values of two newly designed compounds showed good agreements with predictions. These data indicate that established models show strong predictability. This will be useful in further investigation of σ1 receptor-ligand interactions and in designing new piperazine ligands with high affinity for σ1 receptors.
出处 《北京师范大学学报(自然科学版)》 CAS CSCD 北大核心 2008年第6期605-609,F0003,共6页 Journal of Beijing Normal University(Natural Science)
基金 国家自然科学基金资助项目(20501004)
关键词 σ1受体配体 哌嗪类化合物 比较分子力场 比较分子相似性指数 B3LYP/6-31G(d) σ1 receptor ligands piperazines CoMFA CoMSIA B3LYP/6-31G(d)
  • 相关文献

参考文献22

  • 1Collier T L, Waterhouse R N, Kassiou M. Imaging sigma receptors: applications in drug development [J]. Current Pharmaceutical Design, 2007, 13:51
  • 2Hashimoto K, Ishiwata K. Sigma receptor ligands.- possible application as therapeutic drugs and as radiopharmaceuticals[J]. Current Pharmaceutical Design, 2006, 12 : 3857
  • 3Vilner B J, John C S, Bowen W D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines [J]. Cancer Res, 1995, 55:408
  • 4Bourrie B, Bribes E, Derocq J M, et al. Sigma receptor ligands: applications in inflammation and oncology[J]. Curr Opi Invest Drugs, 2004, 5:1158
  • 5Quirion R, Bowen W D, Itzhak Y, et al. A proposal for the classification of sigma binding sites [J]. Trends Pharmacol Sci, 1992, 13:85
  • 6Mach R H, Smith C R, Al-Nabulsi I, et al. δ2 receptors as potential biomarkers of proliferation in breast cancer [J]. Cancer Res, 1997; 57:156
  • 7Wheeler K T, Wang L M, Wallen C A, et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours [J]. BrJ Cancer, 2000, 82:1223
  • 8张秋艳,樊彩云,贾红梅.Sigma受体显像剂[J].化学进展,2007,19(5):713-721. 被引量:2
  • 9Glennon R A, Yousif M Y, Ismaiel A M, et al. Novel 1- phenylpiperazine and 4-phenylpiperidine derivatives as high-affinity δ ligands [J]. J Med Chem, 1991, 34;3360
  • 10Zhang Y, Williams W, Torrence-Campbell C, et al. Characterization of novel N, N'-disubstituted piperazines as δ receptor ligands [J]. J Med Chem, 1998, 41:4950

二级参考文献68

  • 1张春丽,刘巧平,王荣福,付占立,刘伯里.^(125)I-4-(N-苄基哌啶基)-4-碘代苯磺酰胺的体内σ受体亲和性能研究[J].同位素,2004,17(4):198-203. 被引量:3
  • 2Martin W R,Eades C E,Thompson J A,et al.J.Pharmacol.Exp.Ther.,1976,197:517-532
  • 3Quirion R,Bowen W D,Itzhak Y,et al.Trends Pharmacol.Sci.,1992,13:85-86
  • 4Hellewell S B,Bowen W D.Brain Res.,1990,527:244-253
  • 5Hellewell S B,Bruce A,Feinstein G,et al.Eur.J.Pharmacol.,1994,268:9-18
  • 6Moebius F F,Striessnig J,Glossmann H.Trends Pharmacol.Sci.,1997,18:67-70
  • 7Prasad P D,Li H W,Fei Y J,et al.J.Neurochem.,1998,70:443-451
  • 8Mei J,Pasternak G W.Biochem.Pharmacol.,2001,62:349-355
  • 9Hayashi T,Su T P.J.Pharmacol.Exp.Ther.,2003,306:726-733
  • 10Aydar E,Palmer C P,Djamgoz M B.Cancer Res.,2004,64:5029-5035

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部